Search

everythinglearnresearchcommunity

for

Search:↓

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Keratins are crucial for tissue strength, and mutations in keratin genes can lead to various diseases, highlighting the need for targeted therapies.

Hormonal balance is vital for women's health and performance, but therapies like contraceptives and steroids have both benefits and risks.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

The link between anabolic agents and colorectal cancer risk is unclear.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Adding a second method to PROTACs could improve cancer treatment.

Genetic differences affect COVID-19 severity and treatment development.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.